rs61729710
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001378609.3(OTOGL):c.5227T>A(p.Leu1743Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000623 in 1,595,370 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.5227T>A | p.Leu1743Ile | missense_variant | 44/59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.5227T>A | p.Leu1743Ile | missense_variant | 44/59 | 5 | NM_001378609.3 | ENSP00000447211.2 | ||
OTOGL | ENST00000646859.1 | c.5092T>A | p.Leu1698Ile | missense_variant | 48/63 | ENSP00000496036.1 | ||||
OTOGL | ENST00000298820.7 | c.526T>A | p.Leu176Ile | missense_variant | 5/18 | 5 | ENSP00000298820.3 |
Frequencies
GnomAD3 genomes AF: 0.00328 AC: 499AN: 152182Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.000833 AC: 180AN: 216076Hom.: 1 AF XY: 0.000714 AC XY: 83AN XY: 116188
GnomAD4 exome AF: 0.000342 AC: 493AN: 1443070Hom.: 1 Cov.: 32 AF XY: 0.000321 AC XY: 230AN XY: 715812
GnomAD4 genome AF: 0.00329 AC: 501AN: 152300Hom.: 3 Cov.: 32 AF XY: 0.00314 AC XY: 234AN XY: 74468
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | OTOGL: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Leu1734Ile in exon 43 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 1.0% (37/3654) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs61729710). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at